// App-Quantinova.ai

554 : Breast cancer specific quality of life in HR+/HER2- advanced/metastatic breast cancer patients in a real-world setting.

Researchers

Presenter

  • Robert Wood

Principal Investigators

  • Debanjali Mitra

  • Jonathan De Courcy

  • Shrividya Iyer

Medical Centers

  • Adelphi Real World, Cheshire, United Kingdom

  • Pfizer Inc, New York, NY

Locations

  • United States

  • United Kingdom

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved